Skip to main content

Table 2 Descriptive characteristics of subjects with tPSA 4–10 ng/mL

From: Usefulness of the prostate health index in predicting the presence and aggressiveness of prostate cancer among Korean men: a prospective observational study

 

Total

No cancer

Cancer

P value

 

N, 77

 N, 48 (62.3%)

N, 29 (37.7%)

Age, yr

68.0 (12.0)

66.5 (11.0)

71.0 (12.0)

0.010

tPSA, ng/mL

6.41 (2.5)

6.42 (2.3)

6.13 (2.8)

0.877

fPSA

0.92 (0.5)

0.97 (0.6)

0.92 (2.4)

0.185

%fPSA

15.49 (8.6)

16.83 (7.5)

13.04 (7.1)

0.284

p2PSA, pg/mL

16.86 (17.5)

15.34 (16.1)

17.09 (23.7)

0.189

%p2PSA

1.61 ( 1.6)

1.50 (1.0)

2.35 (2.6)

0.015

PHI

41.35 (37.9)

39.65 (28.9)

53.72 (56.8)

0.018

Positive core number

4.0 (7.0)

Number (percentage)

GS 6

9 (31%)

GS 7

  

10 (34.5%)

GS ≥ 8

  

10 (34.5%)

  1. Data are shown as median (interquartile range), or number (%)
  2. PSA, prostate-specific antigen; tPSA, total PSA; fPSA, free PSA; p2PSA, [2]proPSA; PHI, prostate health index; GS, Gleason score
  3. P value to be statiscally significant with bolditalics